Trial intelligence / Profile preview

PNOC029 tovorafenib for newly diagnosed or recurrent craniopharyngioma in children and young adults

NL-OMON61022Phase 2Not yet recruiting

Sponsor

Princess Máxima Center for Pediatric Oncology

Start

Jan 2026

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1